These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9172943)
1. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Maggs JL; Pirmohamed M; Kitteringham NR; Park BK Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943 [TBL] [Abstract][Full Text] [Related]
2. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s). Madden S; Maggs JL; Park BK Drug Metab Dispos; 1996 Apr; 24(4):469-79. PubMed ID: 8801063 [TBL] [Abstract][Full Text] [Related]
3. Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry. Lynn RK; Smith RG; Thompson RM; Deinzer ML; Griffin D; Gerber N Drug Metab Dispos; 1978; 6(4):494-501. PubMed ID: 28932 [TBL] [Abstract][Full Text] [Related]
4. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Lu W; Uetrecht JP Drug Metab Dispos; 2008 Aug; 36(8):1624-36. PubMed ID: 18463199 [TBL] [Abstract][Full Text] [Related]
5. N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. Staines AG; Coughtrie MW; Burchell B J Pharmacol Exp Ther; 2004 Dec; 311(3):1131-7. PubMed ID: 15292462 [TBL] [Abstract][Full Text] [Related]
6. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization. Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835 [TBL] [Abstract][Full Text] [Related]
7. Carbamazepine: detection of another metabolite in serum, 9 hydroxymethyl-10-carbamoyl acridan. Wad N; Guenat C; Krämer G Ther Drug Monit; 1997 Jun; 19(3):314-7. PubMed ID: 9200773 [TBL] [Abstract][Full Text] [Related]
8. Quaternary N-glucuronides of 10-hydroxylated amitriptyline metabolites in human urine. Breyer-Pfaff U; Becher B; Nusser E; Nill K; Baier-Weber B; Zaunbrecher D; Wachsmuth H; Prox A Xenobiotica; 1990 Jul; 20(7):727-38. PubMed ID: 2238706 [TBL] [Abstract][Full Text] [Related]
9. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry. Bu HZ; Zhao P; Dalvie DK; Pool WF Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390 [TBL] [Abstract][Full Text] [Related]
10. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects. Eichelbaum M; Tomson T; Tybring G; Bertilsson L Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637 [TBL] [Abstract][Full Text] [Related]
11. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry. Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083 [TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Kuhnz W; Jäger-Roman E; Rating D; Deichl A; Kunze J; Helge H; Nau H Pediatr Pharmacol (New York); 1983; 3(3-4):199-208. PubMed ID: 6677873 [TBL] [Abstract][Full Text] [Related]
13. Laser evoked potentials and carbamazepine in epileptic patients. Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Panesar SK; Bandiera SM; Abbott FS Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776 [TBL] [Abstract][Full Text] [Related]
15. Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity. Amore BM; Kalhorn TF; Skiles GL; Hunter AP; Bennett GD; Finnell RH; Nelson SD; Slattery JT Drug Metab Dispos; 1997 Aug; 25(8):953-62. PubMed ID: 9280403 [TBL] [Abstract][Full Text] [Related]
16. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite. Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464 [TBL] [Abstract][Full Text] [Related]
17. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring. Vasudev A; Tripathi KD; Puri V Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153 [TBL] [Abstract][Full Text] [Related]
18. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase? Svinarov DA; Pippenger CE Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916 [TBL] [Abstract][Full Text] [Related]
19. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523 [TBL] [Abstract][Full Text] [Related]